Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI)

Q: What does CUSIP 753018100 represent in this 13F holders report?

CUSIP 753018100 is the security identifier for RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share in Q2 2026?

8 institutional investors reported RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 753018100

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Class A Common Stock, $0.0001 par value per share
Total 13F shares: 242,235
Total 13F value: $184,196
Share change: -23,800
SEC-reported price per share: $0.76
Number of holders: 8
Value change: -$17,468
Number of buys: 1
Number of sells: 3
Shares outstanding: 114,373,343

Security key

753018100

Report period

Q2 2026

Institutions

Top holders

RANI full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Rani Therapeutics Holdings, Inc. SEC filings Rani Therapeutics Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 753018100

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

InCube Labs, L.L.C.

Disclosed value leader

AWM Investment Company, Inc.

Comparable rows

15/15

Latest evidence

26 May 2026

13D/G 3/4/5 13F Lead comparable stake: 22% 13D/G row: InCube Labs, L.L.C. Showing 1-6 of 15 holder rows.

Quick read

InCube Labs, L.L.C. leads the comparable SEC ownership view at 22%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens InCube Labs, L.L.C.'s linked filing trail.

Comparable ownership Top 5

InCube Labs, L.L.C. 22%

Invus Global Management, LLC 10%

AWM Investment Company, Inc. 9.9%

Samsara BioCapital, L.P. 9.9%

RA CAPITAL MANAGEMENT, L.P. 9.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
InCube Labs, L.L.C.	13D/G 3/4/5 MIR A IMRAN · 10%+ Owner 13D/G 3/4/5	22%	$13,541,357 27,093,552 shares	$0	23 Oct 2025
Invus Global Management, LLC	13D/G Raymond Debbane 13D/G	10%	$4,910,990 9,825,911 shares	$0	16 Oct 2025
AWM Investment Company, Inc.	13D/G 13F Company 13D/G 13F	9.9%	$14,520,561 9,745,343 shares	$0	31 Dec 2025
Samsara BioCapital, L.P.	13D/G Srinivas Akkaraju 13D/G	9.9%	$10,417,124 11,322,961 shares	+$1,325,245	26 May 2026
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G Company 13F 13D/G	9.9% from 13D/G	$6,245,800 8,500,000 shares	—	31 Mar 2026
VANGUARD GROUP INC	13D/G The Vanguard Group 13D/G	5.2%	$6,897,647 5,109,368 shares	$0	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

242,235

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

-65

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend